HomeCompareATBPF vs FCPT

ATBPF vs FCPT: Dividend Comparison 2026

ATBPF yields 927.64% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ATBPF wins by $9822464.71M in total portfolio value
10 years
ATBPF
ATBPF
● Live price
927.64%
Share price
$0.22
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9822464.76M
Annual income
$8,103,949,924,179.18
Full ATBPF calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — ATBPF vs FCPT

📍 ATBPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodATBPFFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ATBPF + FCPT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ATBPF pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ATBPF
Annual income on $10K today (after 15% tax)
$78,849.72/yr
After 10yr DRIP, annual income (after tax)
$6,888,357,435,552.30/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, ATBPF beats the other by $6,888,357,430,643.31/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ATBPF + FCPT for your $10,000?

ATBPF: 50%FCPT: 50%
100% FCPT50/50100% ATBPF
Portfolio after 10yr
$4911232.41M
Annual income
$4,051,974,964,977.23/yr
Blended yield
82.50%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

ATBPF
No analyst data
Altman Z
-3.8
Piotroski
1/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ATBPF buys
0
FCPT buys
0
No recent congressional trades found for ATBPF or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricATBPFFCPT
Forward yield927.64%6.05%
Annual dividend / share$2.00$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$9822464.76M$49.1K
Annual income after 10y$8,103,949,924,179.18$5,775.28
Total dividends collected$9689719.06M$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: ATBPF vs FCPT ($10,000, DRIP)

YearATBPF PortfolioATBPF Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$103,464$92,764.38$11,401$700.92+$92.1KATBPF
2$1,007,698$896,991.47$13,064$864.84+$994.6KATBPF
3$9,243,012$8,164,775.26$15,051$1,072.48+$9.23MATBPF
4$79,881,224$69,991,201.10$17,442$1,337.22+$79.86MATBPF
5$650,788,343$565,315,433.07$20,340$1,677.08+$650.77MATBPF
6$5,000,639,395$4,304,295,867.45$23,880$2,116.57+$5000.62MATBPF
7$36,261,047,555$30,910,363,402.53$28,241$2,689.36+$36261.02MATBPF
8$248,275,740,228$209,476,419,343.92$33,660$3,442.07+$248275.71MATBPF
9$1,606,088,634,392$1,340,433,592,348.06$40,456$4,439.95+$1606088.59MATBPF
10$9,822,464,762,978$8,103,949,924,179.18$49,063$5,775.28+$9822464.71MATBPF

ATBPF vs FCPT: Complete Analysis 2026

ATBPFStock

Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. The company's drugs are designed to prevent the gastrointestinal damage and bleeding caused by non-steroidal anti-inflammatory drugs. Its lead compound is Otenaproxesul, a hydrogen sulfide-releasing derivative of naproxen for treating post-operative pain, migraine, dysmenorrhea, traumatic injury, dental pain, and gout that has completed Phase 2B gastrointestinal safety study. In addition, the company's products comprise ATB-352, which is in preclinical stage for acute pain. Antibe Therapeutics Inc. was incorporated in 2009 and is headquartered in Toronto, Canada.

Full ATBPF Calculator →

FCPTREIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this ATBPF vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ATBPF vs SCHDATBPF vs JEPIATBPF vs OATBPF vs KOATBPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.